Results 161 to 170 of about 36,030 (253)

Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.

Blood, 2009
C. Becker, C. Taube, T. Bopp, C. Becker, Kai D. Michel, J. Kubach, S. Reuter, N. Dehzad, M. Neurath, K. Reifenberg, F. Schneider, E. Schmitt, H. Jonuleit   +12 more
semanticscholar   +1 more source

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

The chemokine CXCL12 and the HIV‐1 envelope protein gp120 regulate spontaneous activity of Cajal–Retzius cells in opposite directions

Journal of Physiology, 2012
I. Marchionni, Michael Beaumont, G. Maccaferri   +2 more
semanticscholar   +1 more source

Stoichiometry of HIV-1 envelope glycoprotein protomers with changes that stabilize or destabilize the pretriggered conformation. [PDF]

mBio
Zhang Z, Anang S, Wang Q, Nguyen HT, Chen H-C, Chiu T-J, Yang D, Smith AB, Sodroski JG.   +8 more
europepmc   +1 more source

Multi-attribute monitoring (MAM) methodology for glycosylated subunit vaccines. [PDF]

Sci Rep
Shajahan A, Jenkins LM, Barefoot N, Maldonado D, Wolff JJ, Yang Y, Kueltzo LA, Ficca V, Scheideman E, Loukinov I, Carruthers C, Benmohamed D, Gowetski DB, Jiang R, Yang SR, Carlton K, Gall JG, Lei QP.   +17 more
europepmc   +1 more source

J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of <i>Pseudomonas</i> Exotoxin A. [PDF]

Pharmaceuticals (Basel)
Pincus SH, Luo K, Peters T, Gordy JT, Cole FM, Klug G, Ober K, Marcotte TK, Markham RB.   +8 more
europepmc   +1 more source

Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits. [PDF]

NPJ Vaccines
Radvan F, Hauser A, Lin LY, Wilmschen-Tober S, Schaber M, Bermejo-Jambrina M, Agbabiaka TO, Peterhoff D, Riepler L, Mendrzyk N, Beierfuß A, Speth C, Moog C, von Laer D, Wagner R, Kimpel J.   +15 more
europepmc   +1 more source

Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico. [PDF]

Int J Mol Sci
Davydenko VS, Shchemelev AN, Ostankova YV, Anufrieva EV, Totolian AA.   +4 more
europepmc   +1 more source

Understanding the performance of HIV-1 viral vector vaccines: adenovirus and poxvirus case studies. [PDF]

Front Immunol
Manafi MM, Farzani T, Espinoza N, Ozonoff A, Sabeti PC.   +4 more
europepmc   +1 more source

Immunogenicity of HIV-1 Env-Gag VLP mRNA and Adenovirus Vector Vaccines in Mice. [PDF]

Vaccines (Basel)
Yang J, Ma Q, He X, Li H, Zhang X, Hao Y, Feng X.   +6 more
europepmc   +1 more source